A new biotech firm is leveraging artificial intelligence to accelerate the discovery of novel medicines from natural sources. Historically, serendipitous discoveries in plants led to drugs like aspirin and metformin. The company aims to streamline this process by using AI to analyse the vast chemical diversity found in nature.
By applying machine learning to large datasets of natural compounds, the biotech hopes to identify promising drug candidates more efficiently. This approach could significantly reduce the time and cost associated with traditional drug discovery methods. The success of this venture could lead to a new wave of pharmaceuticals derived from nature's untapped medicinal potential.
Subscribe for Weekly Updates
Stay ahead with our weekly AI and tech briefings, delivered every Tuesday.
